Provide RCT enrollment and regulatory update for ATA188
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 11 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- Q1 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Q1 2021: RCT enrollment and regulatory update”
What we found
Evidence strength A What the grades mean
The company provided a regulatory update in Q1 2021 regarding the approval of a Clinical Trial Application in Canada and continued to report on enrollment progress for the ATA188 RCT.
-
A Atara Biotherapeutics, Inc. 10-Q filed 2021-05-04
“In the first quarter of 2021, we filed and received approval of a Clinical Trial Application for the Phase 2 RCT in Canada.” ✓ confirmed on the page
-
A Atara Biotherapeutics, Inc. 10-Q filed 2021-05-04
“We also continue to enroll patients in a randomized, double-blind, placebo-controlled trial (Phase 2 RCT) evaluating the efficacy and safety of ATA188 in patients with PMS.” ✓ confirmed on the page
Market reaction: the shares moved -8.5% against the S&P 500 over the three sessions around the disclosure (3 May 2021 to 6 May 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Provide
- Deliverable
- RCT enrollment and regulatory update
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and reads it as “no_evidence”.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Atara Biotherapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ATRA-021589 · Corrections policy